Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy-Reference-Cited by-同舟云学术

Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy

Published:2017-09 Issue:Supplement 2 Volume:58 Page:67S-76S
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Eiber Matthias,Fendler Wolfgang P.,Rowe Steven P.,Calais Jeremie,Hofman Michael S.,Maurer Tobias,Schwarzenboeck Sarah M.,Kratowchil Clemens,Herrmann Ken,Giesel Frederik L.

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference124 articles.

1. Global cancer statistics, 2012

2. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

3. Multiparametric prostate magnetic resonance imaging in the evaluation of prostate cancer

4. Role of multiparametric magnetic resonance imaging in early detection of prostate cancer;De Visschere;Insights Imaging.,2016

5. MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study

Cited by 168 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Positron emission tomography computed tomography in the diagnosis of prostate cancer;Karnataka Medical Journal;2024-09-03

2. Evaluation of a bimodal, matched pair theranostic agent targeting prostate-specific membrane antigen;Nuclear Medicine and Biology;2024-09

3. Internal dosimetry assessment of beta, beta/auger, and alpha decaying radionuclides in targeted radionuclide therapy for prostate cancer: a simulation study;Physica Scripta;2024-07-30

4. 18F-PSMA-1007 PET/MR for Early Detection of Biochemical Recurrence of Prostate Cancer in Very Low (≤ 0.5 ng/mL) Prostate-Specific Antigen Levels;2024-07-12

5. Expanding Role for Gallium-68 PET Imaging in Oncology;Seminars in Nuclear Medicine;2024-07